Skip to content
Friday 21 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,758.49
+0.10%
DAX
26,017.09
+0.13%
CAC 40
8,457.82
+0.06%
STOXX 50
6,435.89
+0.22%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 31 May 2016 5:59 pm

Deutsche Boerse could become US takeover target if London Stock Exchange merger fails, chief executive says

By: William Turvill

Add as a preferred source on Google

Deutsche Boerse could become a US takeover target if its merger with the London Stock Exchange (LSE) fails, its chief executive has said.

Carsten Kengeter has suggested Chicago-based CME Group could become interested in the German company should the £21bn “merger of equals” fail.

Speaking of potential interest from CME Group, Kengeter said: “I don’t really think this will crystallise at the moment but they could articulate it if our merger is unsuccessful.”

Read more: French government sticks oar in to London Stock Exchange merger deal

Speaking at the ICFW Frankfurt international business journalists’ club he also said that if the deal were to fail, Deutsche Boerse would need to seek other partners, Reuters reported.

Kengeter added: “I would have various suggestions but whether it came to exercising these options is a different question.”

He also told the group that Deutsche Boerse had looked at a number of possible combinations over the last year but that the LSE proved the best option.

Read more: London Stock Exchange shareholders set to vote on merger after referendum

Analysts are far from certain the tie-up with go through, with Credit Suisse, Exane BNP Paribas, Numis and Morgan Stanley all warning of the many hurdles the deal faces in recent weeks.

The deal received a boost over the weekend when Children’s Investment Fund (TCI) founder Christopher Hohn indicated his activist hedge fund, an LSE shareholder, would back the deal.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • M&A

Trending Articles

  • House prices in wealthy London boroughs fall by up to £300,000

  • As it happened: Miners fuel FTSE 100 recovery; oil jumps as Trump claims Strait of Hormuz

  • City law firm sues prominent Emirati business family

  • Amanda Blanc has worked her magic at Aviva

  • As it happened: FTSE 100 rallies after JD Sports drags on blue chips; oil jumps again

More from Morning Wire

  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Hogan Lovells Cadwalader looks to tap transatlantic dealmaking boom following merger

    Legal
    Canada
  • Forvis Mazars and top partner hit with £600,000 fine for audit failings

    Accountancy
    Canada skyline representing the potential legal impact of Labours flexible working reforms on businesses
  • Finsbury lines up Games Workshop splurge using merger windfall

    Investing
    Games Workshop worked its way into the FTSE 100 last year.
  • Associated British Foods rises to bread battle with Warburtons

    Retail
    Artisan bread loaves on display, symbolizing Associated British Foods strategic merger challenge to Warburtons in the brea...
  • Cavendish taps top adviser to fend off foreign takeover interest

    Advisory
    St Pauls Cathedral in London, framed by modern glass buildings under a clear sky, near Cavendishs base
  • Engineering group picked off London Stock Exchange in £4.1bn deal

    Markets
    Rotork industrial machinery in manufacturing plant showcasing advanced automation technology and engineering excellence
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook